News

insert an image 968px x 220px

News

Gentronix Awarded Grant from the Biomedical Catalyst Programme for an Epigenetic Based Screening Assay Feasibility Study.

Posted on December 11, 2012 by Chris Hughes

Gentronix Ltd., Manchester UK, has been awarded a grant of £147,552 by the Medical Research Council (MRC) and the Technology Strategy Board under the joint £180 million Biomedical Catalyst programme. The project funded by the award will look at the feasibility of developing a screening assay for compounds that may cause cancer as a result of epigenetic mechanisms.

Read the rest of this news item

Innovative Early Stage Test For Personal Care Product Safety

Posted on December 11, 2012 by Chris Hughes

BlueScreen™ HC can be used to provide a rapid assessment of potential genotoxic hazard and thereby accelerate the development of personal care and other products.

Read the rest of this news item

Gentronix Receives French Research Tax Credit Accreditation

Posted on November 1, 2012 by Chris Hughes

Gentronix Limited, the genotoxicity innovation and service company, is pleased to announce that it has received French research tax credit approval for years 2012 through 2014.

Read the rest of this news item

Independent evaluation of GreenScreen published by Galderma

Posted on October 1, 2012 by Chris Hughes

French dermatology company Galderma has published a paper on the evaluation of GreenScreen HC in the Journal of Applied Toxicology. Evaluation of the GADD45α-GFP GreenScreen HC assay for rapid and reliable in vitro early genotoxicity screening., A.P. Luzy,N. Orsini, J.M. Linget, G. Bouvier. An e-publication (ahead of print) can be sourced from here. In the paper, 22 of Galderma’s proprietary compounds were tested using GreenScreen HC, the SOS-ChromoTest and Mini-Ames. A further 40 characterised compounds were also tested. With the proprietary compounds the study concluded that GreenScreen HC renders the SOS-ChromoTest obsolete for in vitro screening. GreenScreen confirmed all results…

Read the rest of this news item